NASDAQ:FLXN

Flexion Therapeutics Stock Forecast

etoro logo Buy FLXN
*Your capital is at risk
$25.10
-0.0069 (-0.0275%)
At Close: Jun 22, 2026
AI Analysis AI Analysis of FLXN AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add FLXN to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Flexion Therapeutics Inc. stock price ended at $25.10 on Monday, after losing 0.0275%
(Updated on Jun 22, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jun 12, 2026 Gain 0.16%

The Flexion Therapeutics Inc. stock price fell by -0.0275% on the last day (Monday, 22nd Jun 2026) from $25.11 to $25.10. During the last trading day the stock fluctuated 0.319% from a day low at $25.05 to a day high of $25.13. The price has been going up and down for this period, and there has been a 0.97% gain for the last 2 weeks. Volume has increased on the last day by 2 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 4 thousand shares were bought and sold for approximately $109.74 thousand.

The stock is moving within a narrow and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Flexion Therapeutics Inc. stock with a 90% probability to be traded between $24.42 and $25.12 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

FLXN Signals & Forecast

The Flexion Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $25.08 and $25.03. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 1.01%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Flexion Therapeutics Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The stock had a Golden Star Signal on Friday, June 12, 2026 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star

The stock had a Golden Star Signal on Friday, June 12, 2026 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Flexion Therapeutics Inc. stock

Flexion Therapeutics Inc. finds support from accumulated volume at $25.02 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.0800 between high and low, or 0.319%. For the last week the stock has had daily average volatility of 0.265%.

Our recommended stop-loss: $23.93 (-4.66%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 7 days ago.)

Trading Expectations (FLXN) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Flexion Therapeutics Inc. to open at $25.09, and during the day (based on 14 day Average True Range), to move between $25.05 and $25.15, which gives a possible trading interval of +/-$0.102 (+/-0.41%) up or down from last closing price. If Flexion Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 0.41% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $25.13 (0.12%) than the support at $25.02 (0.32%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Flexion Therapeutics Inc. stock A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Flexion Therapeutics Inc. stock to perform well in the short-term period.

Current score: 2.420 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $25.09 ( 0.0266%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

FLXN Performance

Trading levels for FLXN

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 25.17 0.292%
R2 25.14 0.170%
R1 25.12 0.0952%
Price 25.10
S1 25.06 -0.148%
S2 25.04 -0.224%
S3 25.01 -0.345%

Accumulated Volume Support & Resistance Levels

Level Price
R3 25.77 2.67%
R2 25.72 2.47%
R1 25.13 0.120%
Price 25.10
S1 25.02 -0.318%
S2 25.01 -0.358%
S3 25.01 -0.359%

FLXN Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 28, 2026 May 28, 2026 May 29, 2026 $0.190 0.759%
2 Apr 27, 2026 Apr 27, 2026 Apr 28, 2026 $0.683 2.73%
3 Feb 27, 2026 Feb 27, 2026 Mar 02, 2026 $0.115 0.450%
4 Dec 24, 2025 Dec 24, 2025 Dec 26, 2025 $0.739 2.91%
5 Aug 22, 2025 Aug 22, 2025 Aug 22, 2025 $0.146 0.577%

FAQ

What is the symbol for Flexion Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Flexion Therapeutics Inc. is FLXN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Flexion Therapeutics Inc. Stock?
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Flexion Therapeutics Inc. stock to perform well in the short-term period.

How to buy Flexion Therapeutics Inc. Stock?
Flexion Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Flexion Therapeutics Inc. Stock.

What's the current price of Flexion Therapeutics Inc. Stock?
As of the end of day on the Jun 22, 2026, the price of an Flexion Therapeutics Inc. (FLXN) share was $25.10.

What is the 52-week high and low for Flexion Therapeutics Inc. Stock?
The 52-week high for Flexion Therapeutics Inc. Stock is $26.09 and the 52-week low is $9.14.

What is the market capitalization of Flexion Therapeutics Inc. Stock?
As of the Jun 22, 2026, the market capitalization of Flexion Therapeutics Inc. is 497.131K.
Click to get the best stock tips daily for free!
ABOUT FLEXION THERAPEUTICS INC.
Flexion Therapeutics
Flexion Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It lead product candidate includes Zilretta, a sustained-release intra-articular steroid, which is in clinical trials to treat the patients with moderate to severe osteoarthritis (OA) pain. The company is also developing FX007, a...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE